Prognostic factors of breast cancer brain metastasis

doi:10.5306/wjco.v15.i1.5

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1576)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

WORD

HTML

1322

Sum=1354

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

131

Sum=180

Jan 24, 2024 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Jan 24, 2024; 15(1): 5-8
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.5

Prognostic factors of breast cancer brain metastasis

Melek Yakar, Durmuş Etiz

Melek Yakar, Department of Radiation Oncology, Osmangazi University, Eskişehir 26040, Turkey

Durmuş Etiz, Department of Radiation Oncology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir 26040, Turkey

Author contributions: Yakar M and Etiz D contributed to this paper; Yakar M designed the overall concept and outline of the manuscript; Etiz D contributed to the discussion and design of the manuscript; Yakar M and Etiz D contributed to the writing, and editing the manuscript, illustrations, and review of literature.

Conflict-of-interest statement: Authors declare no potential conflict of interests for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Melek Yakar, MD, Adjunct Associate Professor, Department of Radiation Oncology, Osmangazi University, Meşelik Campus Büyükdere District Prof. Dr. Nabi AVCI Boulevard No:4 26040 Odunpazarı - Eskişehir, Eskişehir 26040, Turkey. myakar@ogu.edu.tr

Received: October 27, 2023
Peer-review started: October 27, 2023
First decision: November 29, 2023
Revised: December 3, 2023
Accepted: December 28, 2023
Article in press: December 28, 2023
Published online: January 24, 2024

Core Tip

Core Tip: Breast cancer is still the most common cancer in women. Breast cancer is the second most common cancer causing brain metastasis. In breast cancer, the first metastasis occurs to the brain with a rate of 12%. In recent years, the prognosis of breast cancer-related brain metastases has improved, and survival and the patient's quality of life have increased, thanks to both changes in medical treatments and technological advances in radiotherapy. For this reason, early diagnosis of cases is very important. At the same time, survival is not the same in every case of brain metastasis. Identifying cases with low survival seems to be very important in paving the way for studies to change treatment strategies.